The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma-Reference-Cited by-同舟云学术

The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma

Published:2011-05-02 Issue:42 Volume:30 Page:4339-4349
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Banerjee R,Mani R-S,Russo N,Scanlon C S,Tsodikov A,Jing X,Cao Q,Palanisamy N,Metwally T,Inglehart R C,Tomlins S,Bradford C,Carey T,Wolf G,Kalyana-Sundaram S,Chinnaiyan A M,Varambally S,D'Silva N J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2011141.pdf

Reference46 articles.

1. Altschuler DL, Ribeiro-Neto F . (1998). Mitogenic and oncogenic properties of the small G protein Rap1b. Proc Natl Acad Sci USA 95: 7475–7479.

2. Beke L, Nuytten M, Van Eynde A, Beullens M, Bollen M . (2007). The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the polycomb group protein EZH2. Oncogene 26: 4590–4595.

3. Bos JL, de Rooij J, Reedquist KA . (2001). Rap1 signalling: adhering to new models. Nat Rev Mol Cell Biol 2: 369–377.

4. Bracken AP, Helin K . (2009). Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer 9: 773–784.

5. Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, Tomlins SA et al. (2008). Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 27: 7274–7284.

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proximity ligation‐based sequencing for the identification of human papillomavirus genomic integration sites in formalin‐fixed paraffin embedded oropharyngeal squamous cell carcinomas;Journal of Medical Virology;2024-08

2. LncRNA AC100826.1 regulated PLCB1 to promote progression in non‐small cell lung cancer;Thoracic Cancer;2024-05-22

3. Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments;Cancer Reports;2024-03

4. Development of microRNA as diagnostic markers in head and neck cancer;Diagnostic, Prognostic, and Therapeutic Role of MicroRNAs in Head and Neck Cancer;2024

5. LncRNA AC100826.1 regulated PLCB1 to promote progression in non-small cell lung cancer;2023-08-17